Open-mkt buys · 90d
—
0 trades · 0 insiders
Open-mkt sales · 90d
—
0 trades · 0 insiders
Net · 90d
$0
Insiders on file
15
Daily buy vs sell · 90 days
No data yet.
Insiders
| Insider | Role | Trades | Bought | Sold | Last trade |
|---|---|---|---|---|---|
| Reinke Kristin Marie K | Director | 1 | $0 | $0 | 2026-09-29 |
| HRTG PV, L.P. | 10% Owner | 1 | $50.00M | $0 | 2026-06-22 |
| NELSEN ROBERT | Director, 10% Owner | 5 | $20.00M | $0 | 2026-06-22 |
| BERNS PAUL L | Director, 10% Owner | 6 | $20.00M | $0 | 2026-06-22 |
| Edelberg Jay | Chief Medical Officer | 3 | $0 | $0 | 2026-06-17 |
| Johnson Keith Bryon | 10% Owner | 8 | $0 | $0 | 2026-06-17 |
| Jahn Brianne | Chief Financial Officer | 1 | $0 | $0 | 2026-06-17 |
| Pasternak Andy | Chief Strategy Officer | 1 | $0 | $0 | 2026-06-17 |
| Moriarty John B | Chief Legal Officer | 1 | $0 | $0 | 2026-06-17 |
| Giordano Douglas E. | Director | 1 | $0 | $0 | 2026-06-17 |
| GIANAKAKOS ANASTASIOS | President & CEO | 6 | $0 | $0 | 2026-06-17 |
| Meeker David P | Director | 1 | $0 | $0 | 2026-06-17 |
| Walbert Timothy P | Director | 2 | $0 | $0 | 2026-06-17 |
| Popovits Kimberly J | Director | 1 | $0 | $0 | 2026-06-17 |
| EDELMAN JOSEPH | Director | 1 | $0 | $0 | 2026-06-17 |
Trade history
| Insider | Role | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|---|
| Reinke Kristin Marie K | Director | A Award deriv | 2026-09-29 | 2026-10-01 | 48,368 | — | $0 | 48,368 | SEC↗ |
| NELSEN ROBERT | Director, 10% Owner | P Buy | 2026-06-22 | 2026-06-24 | 1,250,000 | $16.00 | $20.00M | 15,042,035 | SEC↗ |
| BERNS PAUL L | Director, 10% Owner | P Buy | 2026-06-22 | 2026-06-24 | 1,250,000 | $16.00 | $20.00M | 15,042,035 | SEC↗ |
| HRTG PV, L.P. | 10% Owner | P Buy | 2026-06-22 | 2026-06-24 | 3,125,000 | $16.00 | $50.00M | 14,866,868 | SEC↗ |
| EDELMAN JOSEPH | Director | A Award | 2026-06-17 | 2026-07-13 | 20,706 | — | $0 | 20,706 | SEC↗ |
| Edelberg Jay | Chief Medical Officer | C Conversion deriv | 2026-06-17 | 2026-06-22 | 61,268 | — | $0 | 0 | SEC↗ |
| GIANAKAKOS ANASTASIOS | President & CEO | C Conversion deriv | 2026-06-17 | 2026-06-22 | 25,742 | — | $0 | 0 | SEC↗ |
| GIANAKAKOS ANASTASIOS | President & CEO | C Conversion deriv | 2026-06-17 | 2026-06-22 | 18,020 | — | $0 | 0 | SEC↗ |
| GIANAKAKOS ANASTASIOS | President & CEO | C Conversion deriv | 2026-06-17 | 2026-06-22 | 313,092 | — | $0 | 0 | SEC↗ |
| Walbert Timothy P | Director | A Award deriv | 2026-06-17 | 2026-06-22 | 57,573 | — | $0 | 57,573 | SEC↗ |
| BERNS PAUL L | Director, 10% Owner | C Conversion deriv | 2026-06-17 | 2026-06-22 | 5,148,587 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | Director, 10% Owner | C Conversion deriv | 2026-06-17 | 2026-06-22 | 1,204,000 | — | $0 | 0 | SEC↗ |
| BERNS PAUL L | Director, 10% Owner | C Conversion deriv | 2026-06-17 | 2026-06-22 | 2,306,401 | — | $0 | 0 | SEC↗ |
| NELSEN ROBERT | 10% Owner | C Conversion deriv | 2026-06-17 | 2026-06-22 | 1,204,000 | — | $0 | 0 | SEC↗ |
| NELSEN ROBERT | 10% Owner | C Conversion deriv | 2026-06-17 | 2026-06-22 | 5,148,587 | — | $0 | 0 | SEC↗ |
| NELSEN ROBERT | 10% Owner | C Conversion deriv | 2026-06-17 | 2026-06-22 | 2,306,401 | — | $0 | 0 | SEC↗ |
| Johnson Keith Bryon | 10% Owner | C Conversion deriv | 2026-06-17 | 2026-06-22 | 3,861,440 | — | $0 | 0 | SEC↗ |
| Johnson Keith Bryon | 10% Owner | C Conversion deriv | 2026-06-17 | 2026-06-22 | 1,287,146 | — | $0 | 0 | SEC↗ |
| Johnson Keith Bryon | 10% Owner | C Conversion deriv | 2026-06-17 | 2026-06-22 | 2,036,033 | — | $0 | 0 | SEC↗ |
| Johnson Keith Bryon | 10% Owner | C Conversion deriv | 2026-06-17 | 2026-06-22 | 1,474,368 | — | $0 | 0 | SEC↗ |
| Edelberg Jay | Chief Medical Officer | C Conversion | 2026-06-17 | 2026-06-22 | 97,587 | — | $0 | 135,543 | SEC↗ |
| Edelberg Jay | Chief Medical Officer | A Award | 2026-06-17 | 2026-06-22 | 47,784 | — | $0 | 183,327 | SEC↗ |
| Giordano Douglas E. | Director | A Award | 2026-06-17 | 2026-06-22 | 20,706 | — | $0 | 20,706 | SEC↗ |
| GIANAKAKOS ANASTASIOS | President & CEO | C Conversion | 2026-06-17 | 2026-06-22 | 41,001 | — | $0 | 2,422,520 | SEC↗ |
| GIANAKAKOS ANASTASIOS | President & CEO | C Conversion | 2026-06-17 | 2026-06-22 | 28,702 | — | $0 | 5,665,090 | SEC↗ |
| GIANAKAKOS ANASTASIOS | President & CEO | C Conversion | 2026-06-17 | 2026-06-22 | 498,692 | — | $0 | 498,692 | SEC↗ |
| Walbert Timothy P | Director | A Award | 2026-06-17 | 2026-06-22 | 20,706 | — | $0 | 20,706 | SEC↗ |
| Popovits Kimberly J | Director | A Award | 2026-06-17 | 2026-06-22 | 20,706 | — | $0 | 20,706 | SEC↗ |
| Jahn Brianne | Chief Financial Officer | A Award | 2026-06-17 | 2026-06-22 | 79,640 | — | $0 | 79,640 | SEC↗ |
| Moriarty John B | Chief Legal Officer | A Award | 2026-06-17 | 2026-06-22 | 47,784 | — | $0 | 47,784 | SEC↗ |
| BERNS PAUL L | Director, 10% Owner | A Award | 2026-06-17 | 2026-06-22 | 20,706 | — | $0 | 20,706 | SEC↗ |
| BERNS PAUL L | Director, 10% Owner | C Conversion | 2026-06-17 | 2026-06-22 | 13,792,035 | — | $0 | 13,792,035 | SEC↗ |
| Meeker David P | Director | A Award | 2026-06-17 | 2026-06-22 | 20,706 | — | $0 | 20,706 | SEC↗ |
| Pasternak Andy | Chief Strategy Officer | A Award | 2026-06-17 | 2026-06-22 | 79,640 | — | $0 | 79,640 | SEC↗ |
| NELSEN ROBERT | 10% Owner | C Conversion | 2026-06-17 | 2026-06-22 | 13,792,035 | — | $0 | 13,792,035 | SEC↗ |
| Johnson Keith Bryon | 10% Owner | C Conversion | 2026-06-17 | 2026-06-22 | 2,348,373 | — | $0 | 11,741,868 | SEC↗ |
| Johnson Keith Bryon | 10% Owner | C Conversion | 2026-06-17 | 2026-06-22 | 3,242,993 | — | $0 | 9,393,495 | SEC↗ |
| Johnson Keith Bryon | 10% Owner | C Conversion | 2026-06-17 | 2026-06-22 | 6,150,502 | — | $0 | 6,150,502 | SEC↗ |
| Johnson Keith Bryon | 10% Owner | C Conversion | 2026-06-17 | 2026-06-22 | 2,050,166 | — | $0 | 2,050,166 | SEC↗ |